INSTITUTION / COMPANY:
Bender Group
WORKSHOP ASSIGNEMENT:
Speaker
Lewis joined the Bender group in 2013 through a BBSRC/AstraZeneca CASE Studentship. His doctoral research involves the development of target prediction & Mechanism-of-Action (MoA) protocols to aid the phenotypic deconvolution of cell-based assays.
Topic: http://www.echeminfo.com/workshop/integrated-tox-modelling-using-chemical-and-biological-information